// App-Quantinova.ai

3721 : A camptothecin-containing nanoparticle-drug conjugate combination with DDR agents provides a novel approach to increasing therapeutic index

Researchers

Presenter

  • Lenka Oplustil OConnor

Principal Investigators

  • Anderson T. Wang

  • David R. Jones

  • Rajesh Odedra

  • Michael Spreadborough

  • Joanne Wilson

  • Aaron Smith

  • Peter Cotton

  • Jaimini Reens

  • Jen Barnes

  • Victoria Sheridan

  • Scott Eliasof

  • Andres Tellez

  • Alan Lau

  • Claire Sadler

  • Mark J. OConnor

Medical Centers

  • AstraZeneca, Alderley Park, United Kingdom

  • Cerulean Pharma Inc., Cambridge, MA

Locations

  • United States

  • United Kingdom

Companies

  • Cerulean Pharma Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • camptothecin

  • Olaparib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved